4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-21-033812
Director bought 727,272 shares at $11.00 ($7,999,992)
- Director acquired 2,187,504 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Katabi Maha · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-18 | Conversion : show line 1 in the form | +2,187,504 | 2,187,504 | I | ||
| 2021-05-18 | Purchase : show line 2 in the form | +727,272 | $11.00 | $7,999,992 | 2,914,776 | I |
| Open-market purchases · 727,272 sh · avg $11.00 · $7,999,992 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-18 | Conversion : show line 3 in the form Series C Preferred Stock | −2,187,504 | 0 | I |
Loading xslF345X03/doc4.xml…